Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Hsp90 is a molecular chaperone for many signal transducers and may influence evolution by releasing previously silent genetic variation in response to environmental change. In fungi separated by ∼800 million years of evolution, Hsp90 potentiated the evolution of drug resistance in a different way, by enabling new mutations to have immediate phenotypic consequences. Resistance was abrogated by Hsp90 inhibitors and by febrile temperatures, suggesting new therapeutic strategies and a clinical benefit of fever. During selection in a human host, drug resistance that was initially Hsp90-dependent evolved toward independence. Thus, Hsp90 can act in diverse ways to couple environmental contingency to the emergence and fixation of new traits.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibitors of heat shock protein 90 (Hsp90)82, calcineurin21,25,26, target of rapamycin (TOR)83 and mutants that affect Rim10184 (a transcription factor involved in the pH response pathway) effectively eliminate tolerance and greatly increase the fungicidal activity [G] of fluconazole across a diverse set of isolates with different tolerance levels (Fig. 1E; Box 5).”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [82]
In the citing paper
“The importance of rendering FLC fungicidal in treating IFIs arises from the increasing prevalence of acquired FLC resistance and the persistent nature of fungal infections attributed to the fungistatic properties of FLC [10,11,12].”
From Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species (2024) · cites this paper as [10]
In the citing paper
“When large numbers of cells are plated on a high concentration of fluconazole, a rapid adaptation to decreased susceptibility has been observed in wild-type cells (25).”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [25]
In the citing paper
“A strain with genetically reduced Hsp90 levels (Lo90 [21]) had a modest reduction in tolerance, however, a concentration the Hsp90 inhibitor GdA that abrogates azole resistance had no effect on MF tolerance (Figure 9D).”
From Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin (2009) · cites this paper as [21]
In the citing paper
“A strain with genetically reduced Hsp90 levels (Lo90 [21]) had a modest reduction in tolerance, however, a concentration the Hsp90 inhibitor GdA that abrogates azole resistance had no effect on MF tolerance (Figure 9D).”
From Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin (2009) · cites this paper as [21]
42 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hsp90 as a capacitor for morphological evolution
Rutherford, S. L., & Lindquist, S. (1998) · Nature · doi:10.1038/24550 · Cited by 2,270
Self-citationPratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Hsp90 as a capacitor of phenotypic variation
Queitsch, C., Sangster, T. A., & Lindquist, S. (2002) · Nature · doi:10.1038/nature749 · Cited by 1,372
Self-citationClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Antifungal agents: mechanisms of action
Odds, F. C., Brown, A. J. P., & Gow, N. A. R. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(03)00117-3 · Cited by 1,202
Kirschner, M., & Gerhart, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8420 · Cited by 1,129
Molecular Evidence for the Early Colonization of Land by Fungi and Plants
Heckman, D. S., Geiser, D. M., Eidell, B. R., Stauffer, R. L., Kardos, N. L., & Hedges, S. B. (2001) · Science · doi:10.1126/science.1061457 · Cited by 1,020
Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980403y · Cited by 1,004
Young, J. C., Moarefi, I., & Hartl, F. U. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104079 · Cited by 822
Research works printed but not linked: 1
- J. R. Blankenship, W. J. Steinbach, J. R. Perfect, J. Heitman, Curr. Opin. Investig. Drugs4, 192 (2003).
Cited by
Items 301–400 of 705
Feder, M. E. (2007) · Journal of Experimental Biology · doi:10.1242/jeb.02725 · Cited by 43
“Although no beneficial mutation has yet been discovered to have arisen by this mechanism in natural or experimental evolution (see Mayr’s criticism of Goldschmidt, above), Lindquist and colleagues have now assembled numerous data consistent with most components of this hypothesis (Cowen and Lindquist, 2005; Queitsch e…”
BackgroundIn Vitro Study of Sequential Fluconazole and Caspofungin Treatment against Candida albicans Biofilms
Sarkar, S., Uppuluri, P., Pierce, C. G., & Lopez-Ribot, J. L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01745-13 · Cited by 41
Re-evaluating the environment in developmental evolution
Moczek, A. P. (2015) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2015.00007 · Cited by 42
“…that exposure to heat stress (or compromising the ability to deal with heat stress) results in the expression of a wide range of phenotypic variants normally rare or absent from natural populations (Rutherford and Lindquist, 1998; Queitsch et al., 2002; Cowen and Lindquist, 2005; Suzuki and…”
BackgroundLi, Y., Chang, W., Zhang, M., Li, X., Jiao, Y., & Lou, H. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov001 · Cited by 36
“In addition, many other elements, such as the molecular chaperone Hsp90 and calcineurin, are also related to the azole resistance (Cowen and Lindquist 2005; Uppuluri et al., 2008).”
BackgroundMultifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans
Xu, Y., Lu, H., Zhu, S., Li, W.-Q., Jiang, Y.-Y., Berman, J., & Yang, F. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00321-21 · Cited by 35
“medium were more tolerant to fluconazole at 30°C than at 39°C (26).”
BackgroundHSP90β promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-κB signaling
Cheng, H.-M., Xing, M., Zhou, Y.-P., Zhang, W., Liu, Z., Li, L., Zheng, Z., Ma, Y., Li, P., Liu, X., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-022-01071-3 · Cited by 34
“HSP90 acts as a molecular chaperone to help protein folding that is important for cell signaling [42].”
BackgroundHeat shock proteins and the calcineurin-crz1 signaling regulate stress responses in fungi
Roy, A., & Tamuli, R. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-02833-w · Cited by 40
“2016), and echinocandin and azole resistance (Cowen and Lindquist 2005) in lower eukaryotes.”
BackgroundInfluentialEvolutionary inspirations for drug discovery
Zhang, H., Chen, L., Li, X., & Zhang, J. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.07.003 · Cited by 39
Antifungal Activity of Geldanamycin Alone or in Combination with Fluconazole Against Candida species
Zhang, J., Liu, W. Y., Tan, J., Sun, Y., Wan, Z., & Li, R. (2013) · Mycopathologia · doi:10.1007/s11046-012-9612-1 · Cited by 36
“essential for survival during membrane stress [10], made drug-resistant isolates drug-susceptible [24].”
InfluentialEfungumab: A Novel Agent in the Treatment of Invasive Candidiasis
Karwa, R., & Wargo, K. A. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m218 · Cited by 34
Casasa, S., & Moczek, A. P. (2018) · Animal Behaviour · doi:10.1016/j.anbehav.2018.01.004 · Cited by 39
“Critical support for the potential of plasticity in shaping evolutionary trajectories derived initially from laboratory studies (e.g. Cowen & Lindquist, 2005; Dworkin, 2005; Queitsch et al., 2002; Rajakumar et al., 2012; Rutherford & Lindquist, 1998; Sikkink et al., 2014; Suzuki & Nijhout, 2006;…”
Gaziano, R., Campione, E., Iacovelli, F., Marino, D., Pica, F., Francesco, P. D., Aquaro, S., Menichini, F., Falconi, M., & Bianchi, L. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s155610 · Cited by 34
Fay, A., Philip, J., Saha, P., Hendrickson, R. C., Glickman, M. S., & Burns-Huang, K. E. (2021) · mBio · doi:10.1128/mbio.00123-21 · Cited by 40
“In the pathogenic fungus Candida albicans, Hsp90 was shown to play a role in AMR to the azoles (6) and the echinocandins (53); in E.”
BackgroundChong, L. P., Wang, Y., Gad, N., Anderson, N. D., Shah, B., & Zhao, R. (2014) · Journal of Experimental Botany · doi:10.1093/jxb/eru403 · Cited by 36
“, 2008), Drosophila (Rutherford and Lindquist, 1998), and fungi (Cowen and Lindquist, 2005), and for plant pathogenrelated disease resistance (Lu et al.”
BackgroundIdentification of novel quaternary domain interactions in the Hsp90 chaperone, GRP94
Chu, F., Maynard, J. C., Chiosis, G., Nicchitta, C. V., & Burlingame, A. L. (2006) · Protein Science · doi:10.1110/ps.052065106 · Cited by 40
“Although the precise chaperone function varies with the nature of its substrates, Hsp90 is thought to either stabilize its client proteins, and thereby prevent their proteasomemediated degradation, and/or maintain client proteins in conformational states suitable for subsequent activation (Richter and Buchner 2001; Pr…”
BackgroundResistance to antifungal therapies
Prasad, R., Banerjee, A., & Shah, A. H. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160067 · Cited by 37
Signaling cascades as drug targets in model and pathogenic fungi.
Bastidas, R. J., Reedy, J. L., Morales-Johansson, H., Heitman, J., & Cardenas, M. E. (2008) · PubMed · Cited by 46
HSP90 AND THE QUANTITATIVE VARIATION OF WING SHAPE IN DROSOPHILA MELANOGASTER
Debat, V., Milton, C. C., Rutherford, S., Klingenberg, C. P., & Hoffmann, A. A. (2006) · Evolution · doi:10.1554/06-045.1 · Cited by 112
“Hsp90 has also been reported to be involved in the evolution of drug resistance in fungi (Cowen and Lindquist 2005).”
BackgroundFu, C., Donadio, N., Cardenas, M. E., & Heitman, J. (2017) · Genetics · doi:10.1534/genetics.117.300422 · Cited by 39
“Several studies have shown synergy between calcineurin inhibitors and other antifungal drugs, which provided new frontiers for novel antifungal therapies (Marchetti et al. 2000; Steinbach et al. 2004; Cowen and Lindquist 2005).”
BackgroundSalvage therapy for invasive aspergillosis
Dockrell, D. H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm426 · Cited by 33
“to cell-wall-active agents such as the echinocandins and suggest another intriguing approach to therapy in the future.(21)”
BackgroundDifferential proteomic analysis of Aspergillus fumigatus morphotypes reveals putative drug targets
Kubitschek-Barreira, P. H., Curty, N., Neves, G. W. P., Gil, C., & Lopes-Bezerra, L. M. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.10.022 · Cited by 39
“albicans and in echinocandins resistance in Aspergillus terreus [50,51].”
BackgroundInvasive candidiasis: update on current pharmacotherapy options and future perspectives
Tragiannidis, A., Tsoulas, C., Kerl, K., & Groll, A. H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.805204 · Cited by 40
“Based on these, HSP 90 inhibitors given in combination with existing antifungal agents may have therapeutic benefits against fungal infections [108-110].”
BackgroundMolecular mechanisms of canalization: Hsp90 and beyond
Salathia, N. S., & Queitsch, C. (2007) · Journal of Biosciences · doi:10.1007/s12038-007-0045-9 · Cited by 37
The relevance of heat shock regulation in fungal pathogens of humans
Brown, A. J. P., Leach, M. D., & Nicholls, S. (2010) · Virulence · doi:10.4161/viru.1.4.12364 · Cited by 30
New antifungal strategies and drug development against WHO critical priority fungal pathogens
Li, Y., Liu, Y., Jiang, Y., Yang, Y., Ni, W., Zhang, W., & Tan, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1662442 · Cited by 53
“Inhibiting Hsp90 markedly reduces resistance to azoles and echinocandins, restoring susceptibility (Cowen and Lindquist, 2005; Singh et al., 2009; Lamoth et al., 2016).”
Mahmoudi, S., Rezaie, S., Ghazvini, R. D., Hashemi, S. J., Badali, H., Foroumadi, A., Diba, K., Chowdhary, A., Meis, J. F. G. M., & Khodavaisy, S. (2019) · Mycopathologia · doi:10.1007/s11046-019-00370-7 · Cited by 33
Chaperone Networks in Fungal Pathogens of Humans
Horianopoulos, L. C., & Kronstad, J. W. (2021) · Journal of Fungi · doi:10.3390/jof7030209 · Cited by 34
“Early work using chemical inhibition established the importance of Hsp90 in the ability of fungi to gain resistance against antifungal drugs [20].”
BackgroundLamoth, F., Juvvadi, P. R., Soderblom, E. J., Moseley, M. A., & Steinbach, W. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00946-15 · Cited by 32
Uncovering cellular circuitry controlling temperature-dependent fungal morphogenesis
Shapiro, R. S., & Cowen, L. E. (2012) · Virulence · doi:10.4161/viru.20979 · Cited by 29
Self-citationFu, C., Beattie, S. R., Jezewski, A. J., Robbins, N., Whitesell, L., Krysan, D. J., & Cowen, L. E. (2022) · Genetics · doi:10.1093/genetics/iyab164 · Cited by 31
Self-citationEpigenetic Regulation of Antifungal Drug Resistance
Patra, S., Raney, M., Pareek, A., & Kaur, R. (2022) · Journal of Fungi · doi:10.3390/jof8080875 · Cited by 37
“Of note, Hsp90 has also been reported to facilitate the emergence of antifungal resistance through its effector molecule, calcineurin, which regulates many fungal stress-response pathways [55].”
BackgroundCai, Y., Lv, Z., Chen, X., Jin, K., & Mou, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134746 · Cited by 36
Alves, R. M. A., Kastora, S. L., Gomes-Gonçalves, A., Azevedo, N. F., Rodrigues, C. F., Silva, S. M., Demuyser, L., Dijck, P. V., Casal, M., Brown, A. J. P., et al. (2020) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-0114-5 · Cited by 34
Structure-guided approaches to targeting stress responses in human fungal pathogens
LeBlanc, E. V., Polvi, E. J., Veri, A. O., Privé, G. G., & Cowen, L. E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.013731 · Cited by 35
“albicans not only impedes the emergence of azole resistance, but also reverses azole resistance acquired in the laboratory or the human host (39).”
BackgroundSelf-citationLarge-Scale Chromosomal Changes and Associated Fitness Consequences in Pathogenic Fungi
Forche, A. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0181-2 · Cited by 36
Synergy Against Fungal Pathogens: Working Together is Better Than Working Alone
Musioł, R., Mrozek‐Wilczkiewicz, A., & Polański, J. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131218094848 · Cited by 35
Combinatorial drug approaches to tackleCandida albicansbiofilms
Cremer, K. D., Staes, I., Delattin, N., Cammue, B. P. A., Thevissen, K., & Brucker, K. D. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1056162 · Cited by 35
“Another related promising target for combination therapy is the chaperone protein Hsp90 which is involved in Candida biofilm resistance to several antifungal compounds, at least partly in a calcineurin-dependent manner [95,96].”
BackgroundHeat Shock Proteins in Dermatophytes: Current Advances and Perspectives
Martinez-Rossi, N. M., Jacob, T. R., Sanches, P. R., Peres, N. T. A., Lang, E. A. S., Martins, M. P., & Rossi, A. (2015) · Current Genomics · doi:10.2174/1389202917666151116212437 · Cited by 34
“albicans to two major classes of antifungals, the azoles and echinocandins [21, 134, 135].”
BackgroundLu, H., Li, W., Whiteway, M., Wang, H., Zhu, S., Ji, Z., Feng, Y., Yan, L., Fang, T., Li, L., et al. (2023) · mBio · doi:10.1128/mbio.02639-22 · Cited by 30
Transcriptional Derepression Uncovers Cryptic Higher-Order Genetic Interactions
Taylor, M. B., & Ehrenreich, I. M. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005606 · Cited by 32
Newer combination antifungal therapies for invasive aspergillosis
Steinbach, W. J., Juvvadi, P. R., Fortwendel, J. R., & Rogg, L. E. (2010) · Medical Mycology · doi:10.3109/13693786.2010.499374 · Cited by 32
Modifiers of the Genotype–Phenotype Map: Hsp90 and Beyond
Schell, R., Mullis, M. N., & Ehrenreich, I. M. (2016) · PLoS Biology · doi:10.1371/journal.pbio.2001015 · Cited by 32
Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance
Harrison, P. T., & Huang, P. H. (2018) · Essays in Biochemistry · doi:10.1042/ebc20180016 · Cited by 34
Phillips, A. M., Doud, M. B., González, L. O., Butty, V. L., Lin, Y., Bloom, J. D., & Shoulders, M. D. (2018) · eLife · doi:10.7554/elife.38795 · Cited by 31
“The reverse transcription reaction was diluted to 80 mL with water, and 2 mL of each sample was used for qPCR with 2 Sybr Green (Roche) and primers for human RPLP2 (housekeeping gene), HSP70, HSP40, HSP90, ERDJ4, GRP94, BIP, SEC24D, and influenza Matrix (primer sequences in Supplementary file 1).”
BackgroundResultInfluentialHorianopoulos, L. C., Hu, G., Caza, M., Schmitt, K., Overby, P., Johnson, J. D., Valerius, O., Braus, G. H., & Kronstad, J. W. (2020) · mBio · doi:10.1128/mbio.01127-20 · Cited by 33
Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
Yuan, R., Tu, J., Sheng, C., Chen, X., & Liu, N. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.680382 · Cited by 35
“albicans, which in turn causes biofilm formation-related resistance (Cowen and Lindquist, 2005; Nett et al., 2011; Whitesell et al., 2019).”
BackgroundWang, H., Ji, Z., Feng, Y., Yan, T., Cao, Y., Lu, H., & Jiang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1101553 · Cited by 30
Chaturvedi, A. K., Weintraub, S. T., Lopez-Ribot, J. L., & Wormley, F. L. (2013) · PROTEOMICS · doi:10.1002/pmic.201300213 · Cited by 32
Zheng, X., Ali Beyzavi, B., Krakowiak, J., Patel, N., Khalil, A. S., & Pincus, D. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.083 · Cited by 32
“…protein folds, Hsp90 has been shown to mask latent genetic variation in fruit flies and plants and to enhance the ability of yeast cells to acquire novel phenotypes, such as resistance to antifungal drugs (Cowen and Lindquist, 2005; Queitsch et al., 2002; Rutherford and Lindquist, 1998).”
BackgroundMethodInfluentialJoanna Masel, A. (2013) · BMC Biology · doi:10.1186/1741-7007-11-103 · Cited by 29
“But the knockout can also hide variants that would otherwise matter, in which case the gene is called a potentiator rather than a capacitor [27,28].”
BackgroundGopinath, R. K., You, S., Chien, K., Swamy, K. B. S., Yu, J., Schuyler, S. C., & Leu, J. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu226 · Cited by 31
“In some cases, Hsp90 buffering facilitates the accumulation of variations to the extent where existing traits are improved or new ones evolve (Cowen and Lindquist 2005; Rohner et al. 2013).”
BackgroundAtorvastatin-induced cell toxicity in yeast is linked to disruption of protein isoprenylation
Callegari, S., McKinnon, R. A., Andrews, S., & de Barros Lopes, M. A. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00593.x · Cited by 28
“These relatively high concentrations, when compared with statin exposure of human cells, are likely due to the naturally occurring drug resistance of yeast (Cowen, 2005; Goffeau, 2008).”
BackgroundThe eagle-like effect of echinocandins: what’s in a name?
Vanstraelen, K., Lagrou, K., Maertens, J., Wauters, J., Willems, L., & Spriet, I. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.841543 · Cited by 28
Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris
Carolus, H., Sofras, D., Boccarella, G., Jacobs, S., Biriukov, V. V., Goossens, L., Chen, A., Vantyghem, I., Verbeeck, T., Pierson, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01811-w · Cited by 30
“The inhibition of Hsp90 by geldana-mycin can reduce azole tolerance 76 and preclude the appearance of azole-resistant cells 92 .”
In Vitro and In Vivo Interactions of TOR Inhibitor AZD8055 and Azoles against Pathogenic Fungi
Sun, Y., Tan, L., Yao, Z., Gao, L., Yang, J. Y., & Zeng, T. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02007-21 · Cited by 29
“Hsp90, a molecular chaperone that stabilizes the calcineurin protein, coordinates cellular circuitry critical for responses to antifungal-induced stress and plays an essential role in antifungal drug resistance (25, 26).”
BackgroundHSP90, a Capacitor of Behavioral Variation
Hung, H., Kay, S. A., & Weber, F. (2009) · Journal of Biological Rhythms · doi:10.1177/0748730409333171 · Cited by 29
Hu, Y., Linz, D. M., Parker, E. S., Schwab, D. B., Casasa, S., Macagno, A. L. M., & Moczek, A. P. (2019) · Evolution & Development · doi:10.1111/ede.12310 · Cited by 33
Zhou, X., Song, N., Li, D., Li, X., & Liu, W. (2021) · mSystems · doi:10.1128/msystems.01316-20 · Cited by 31
“Hsp90 has also been associated with drug resistance (55), and KDACs inhibited the Hsp90-dependent azole tolerance in S.”
BackgroundBiosurfactant production by halophilic yeasts isolated from extreme environments in Botswana
Loeto, D., Jongman, M., Lekote, L., Muzila, M., Mokomane, M., Motlhanka, K., Ndlovu, T., & Zhou, N. (2021) · FEMS Microbiology Letters · doi:10.1093/femsle/fnab146 · Cited by 31
Involvement of Heat Shock Proteins in Candida albicans Biofilm Formation
Becherelli, M., Tao, J., & Ryder, N. S. (2013) · Microbial Physiology · doi:10.1159/000351619 · Cited by 30
“The high-level resistance to antifungal drugs that is associated with mature biofilm is also consistent with the recent findings that Hsp90 is involved in fungal drug tolerance [Cowen and Lindquist, 2005].”
ResultGene Expression and Evolution of Antifungal Drug Resistance
Anderson, J. B., Sirjusingh, C., Syed, N., & LaFayette, S. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01315-08 · Cited by 29
“Last, it is known that resistance via gainof-function mutations in the relevant transcriptional regulators is not sensitive to conditions of low levels of Hsp90 (6).”
BackgroundChaperones as Parts of Cellular Networks
Csermely, P., Sőti, C., & Blatch, G. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-39975-1_6 · Cited by 33
The progress and future of the treatment of Candida albicans infections based on nanotechnology
Gao, Y., Cao, Q., Xiao, Y., Wu, Y., Ding, L., Huang, H., Li, Y., Yang, J., & Meng, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02841-6 · Cited by 33
“It can change the conformation of steroid hormone receptors, regulate the signal transduction pathway of cells, improve the adaptability of fungi to external stimuli and increase the viability of fungi [126].”
BackgroundGenome-scale Co-evolutionary Inference Identifies Functions and Clients of Bacterial Hsp90
Press, M. O., Li, H., Creanza, N., Krämer, G., Queitsch, C., Sourjik, V., & Borenstein, E. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003631 · Cited by 28
“Depletion of eukaryotic Hsp90 in vivo increases phenotypic variation, reveals ‘cryptic’ heritable variation, and increases penetrance of mutations [6–9].”
BackgroundAntifungal adjuvants: Preserving and extending the antifungal arsenal
Butts, A., Palmer, G. E., & Rogers, P. D. (2017) · Virulence · doi:10.1080/21505594.2016.1216283 · Cited by 26
“Recently, it has been shown that depletion of Hsp90 interferes with the development of resistance to azoles and echinocandins.(45,46) As such, inhibition of Hsp90 by the natural product geldanamycin and synthetic analogs, 17-(dimethylaminoethylamino)-”
BackgroundThe Hsp90 Co-chaperones Sti1, Aha1, and P23 Regulate Adaptive Responses to Antifungal Azoles
Gu, X., Xue, W., Yin, Y., Liu, H., Li, S., & Sun, X. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01571 · Cited by 26
“Intensive studies have been done to understand how Hsp90 mediates azole resistance in Saccharomyces cerevisiae, the yeast-like fungus C. albicans, and the filamentous fungus A. fumigatus (Cowen and Lindquist, 2005; Cowen et al., 2006; Cowen, 2009).”
InfluentialEcheverría, P. C., Bhattacharya, K., Joshi, A., Wang, T., & Picard, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0208287 · Cited by 26
“As a consequence, it has been argued that its capacity to buffer the appearance of polymorphic variants by "chaperoning" variant or mutant proteins, a process which may play an important role in evolution, contributes analogously in oncogenesis [61,6,62-64].”
BackgroundAntifungal Drugs: The Current Armamentarium and Development of New Agents
Robbins, N., Wright, G. D., & Cowen, L. E. (2017) · ASM Press eBooks · doi:10.1128/9781555819583.ch44 · Cited by 27
Self-citationDrug resistance in fungi - an emerging problem
Chakrabarti, A. (2011) · Cited by 27
Insights and Perspectives on the Role of Proteostasis and Heat Shock Proteins in Fungal Infections
Neves‐da‐Rocha, J., Santos-Saboya, M. J., Lopes, M. E. R., Rossi, A., & Martinez-Rossi, N. M. (2023) · Microorganisms · doi:10.3390/microorganisms11081878 · Cited by 32
Kumar, S. N., Nisha, G. V., Sudaresan, A., Venugopal, V., Kumar, M., Lankalapalli, R. S., & Kumar, B. S. (2014) · Medical Mycology · doi:10.1093/mmy/myu012 · Cited by 26
“Systems biologists have discovered that pathogenic fungi are composed of complex networking systems with very divergent signaling pathways [34,35].”
BackgroundThe non-Geldanamycin Hsp90 inhibitors enhanced the antifungal activity of fluconazole.
Li, L., An, M., Shen, H., Huang, X., Yao, X., Liu, J., Zhu, F., Zhang, S., Chen, S., He, L., et al. (2015) · PubMed · Cited by 33
Dumeaux, V., Massahi, S., Bettauer, V., Mottola, A., Dukovny, A., Khurdia, S. S., Costa, A. C. B. P., Omran, R. P., Simpson, S., Xie, J. L., et al. (2023) · eLife · doi:10.7554/elife.81406 · Cited by 25
Target- and prodrug-based design for fungal diseases and cancer-associated fungal infections
Liu, N., Tu, J., Huang, Y., Yang, W., Wang, Q., Li, Z., & Sheng, C. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114819 · Cited by 26
A first-in-class inhibitor of Hsp110 molecular chaperones of pathogenic fungi
Hu, L., Sun, C., Kidd, J. M., Han, J., Fang, X., Li, H., Liu, Q., May, A. E., Li, Q., Zhou, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38220-2 · Cited by 26
Hsp21 Potentiates Antifungal Drug Tolerance in Candida albicans
Mayer, F. L., Wilson, D., & Hube, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060417 · Cited by 26
“albicans has been demonstrated to abrogate the emergence of drug resistance [41].”
BackgroundNovel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR inCandida albicans
Hameed, S., & Fatima, Z. (2013) · International Journal of Microbiology · doi:10.1155/2013/240209 · Cited by 28
Potential of Anti- Candida Antibodies in Immunoprophylaxis
Cabezas, J., Albaina, O., Montañez, D., Sevilla, M. J., Moragues, M. D., & Pontón, J. (2010) · Immunotherapy · doi:10.2217/imt.09.76 · Cited by 29
Combination antifungals: an update
Segal, B. H., & Steinbach, W. J. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.883 · Cited by 27
Campione, E., Gaziano, R., Doldo, E., Marino, D., Falconi, M., Iacovelli, F., Tagliaferri, D., Pacello, L., Bianchi, L., Lanna, C., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01874-20 · Cited by 23
“Targeting Hsp90 to reduce stress response compensatory pathways with fungal-specific inhibitors of ATRA may represent an attractive novel antifungal strategy (34).”
BackgroundSmall molecule inhibitors targeting heat shock protein 90: An updated review
Li, Y., Dong, J., & Qin, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116562 · Cited by 25
Stochastic variation in Cardamine hirsuta petal number
Monniaux, M., Pieper, B., & Hay, A. (2015) · Annals of Botany · doi:10.1093/aob/mcv131 · Cited by 24
“Cryptic genetic variation can be revealed by strong perturbations, such as inhibition of Hsp90 (heat shock protein 90) chaperone function, or high environmental stresses such as heat shocks (Rutherford and Lindquist, 1998; Queitsch et al., 2002; Cowen and Lindquist, 2005).”
BackgroundThe Effects of an Hsp90 Inhibitor on the Paradoxical Effect
Kaneko, Y., Ohno, H., Imamura, Y., Kohno, S., & Miyazaki, Y. (2009) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2009.392 · Cited by 23
“Rad also reduced the tolerance to VRC, as previously noted (Fig. 1B) ( 10 ).”
BackgroundResultPrion-like proteins as epigenetic devices of stress adaptation
Oamen, H. P., Lau, Y., & Caudron, F. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112262 · Cited by 21
Signalling mechanisms involved in stress response to antifungal drugs
Víglaš, J., & Olejníková, P. (2020) · Research in Microbiology · doi:10.1016/j.resmic.2020.10.001 · Cited by 24
Matos, T. G. F., Morais, F. V., & de Campos, C. B. L. (2012) · Medical Mycology · doi:10.3109/13693786.2012.725481 · Cited by 23
Wang, X. (2021) · Infectious diseases · doi:10.5772/intechopen.87410 · Cited by 22
Groll, A. H., & Grist, L. M. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.08.014 · Cited by 22
Identification of a Cell Death Pathway in Candida albicans during the Response to Pheromone
Alby, K., Schaefer, D., Sherwood, R. K., Jones, S. K., & Bennett, R. J. (2010) · Eukaryotic Cell · doi:10.1128/ec.00155-10 · Cited by 23
Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches
Xiong, J., Lu, H., & Jiang, Y. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00657 · Cited by 20
Small molecules restore azole activity against drug-tolerant and drug-resistant Candida isolates
Alabi, P., Gautier, C., Murphy, T. P., Gu, X., Lepas, M., Aimanianda, V., Sello, J. K., & Ene, I. V. (2023) · mBio · doi:10.1128/mbio.00479-23 · Cited by 30
Epigenetic Mechanisms Underlying Developmental Plasticity in Horned Beetles
Valena, S., & Moczek, A. P. (2012) · Genetics Research International · doi:10.1155/2012/576303 · Cited by 23
Kellermann, V., Hoffmann, A. A., & Sgrò, C. M. (2007) · Biological Journal of the Linnean Society · doi:10.1111/j.1095-8312.2007.00875.x · Cited by 21
Malavazi, I., Ferreira, M. E. D. S., Soriani, F. M., Dinamarco, T. M., Savoldi, M., Uyemura, S. A., Goldman, M. H. S., & Goldman, G. H. (2009) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.06.009 · Cited by 24
“Calcineurin is not only required for azole resistance mediated by loss of function of Erg3 but also for resistance due to multiple mechanisms found in clinical isolates (Cowen et al., 2006; Cowen and Lindquist, 2005; Cowen and Steinbach, 2008).”
BackgroundEpigenetic and Posttranslational Modifications in Regulating the Biology of Aspergillus Species
Nie, X., Li, B., & Wang, S. (2018) · Advances in applied microbiology · doi:10.1016/bs.aambs.2018.05.004 · Cited by 23
Azole potentiation in Candida species
Stenkiewicz-Witeska, J., & Ene, I. V. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011583 · Cited by 22
Antifungal resistance, combinations and pipeline: oh my!
Stover, K. R., Hawkins, B. K., Keck, J. M., Barber, K. E., & Cretella, D. A. (2023) · Drugs in Context · doi:10.7573/dic.2023-7-1 · Cited by 22
Selection for robust metabolism in domesticated yeasts is driven by adaptation to Hsp90 stress
Patel, D., Amiji, H., Shropshire, W., Condic, N., Lermi, N. O., Sabha, Y., John, B., Hanson, B., & Karras, G. I. (2024) · Science · doi:10.1126/science.adi3048 · Cited by 23
“Of those stressors, ethanol exposure has been shown to compromise Hsp90 function and the folding of client proteins within yeast cells ( 63 , 64 ), and elevated temperature has been demonstrated to abrogate Hsp90-dependent resistance to antifungal agents ( 28 ).”
BackgroundThe Ins and Outs of Azole Antifungal Drug Resistance: Molecular Mechanisms of Transport
Zavřel, M., Esquivel, B. D., & White, T. C. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_29 · Cited by 24
“In cells, Hsp90 functions in drug resistance through the calcineurin pathway, which is known to be implicated in virulence of several pathogenic fungi and also enables fungal cells to tolerate ergosterol biosynthesis inhibitors (Cowen and Lindquist 2005).”
BackgroundInfluentialWhat Has a Century of Quantitative Genetics Taught Us About Nature's Genetic Tool Kit?
Jakobson, C. M., & Jarosz, D. F. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-021920-102037 · Cited by 19
Metadata
- Authors
- Cowen, L. E., & Lindquist, S.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Lindquist, Susan
- ORCID
- Cowen, Leah E.
- Venue
- Science
- Published
- 2005-09-30
- Volume
- 309
- Issue
- 5744
- Pages
- 2185-2189
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1988825409
- Cited by
- 698
- References
- 36
- Citations by year
- 2026: 21 · 2025: 32 · 2024: 46 · 2023: 30 · 2022: 30 · 2021: 38 · 2020: 34 · 2019: 42 · 2018: 36 · 2017: 25 · 2016: 34 · 2015: 36 · 2014: 39 · 2013: 40 · 2012: 47
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (P30ES002109, P30ES-02109)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- HSP90, molecular chaperones, drug resistance, fungi, Hsp90 inhibitors, fever, febrile temperature, signal transducers, treatment options
- MeSH terms
- Caspofungin, Antifungal Agents, Aspergillosis, Aspergillus, Candida albicans, Candidiasis, Ergosterol, Biological Evolution, Humans, Mutation, Peptides, Cyclic, Phenotype, Saccharomyces cerevisiae, Selection, Genetic, Fluconazole, AIDS-Related Opportunistic Infections, HSP90 Heat-Shock Proteins, Calcineurin, Cyclophilin A, Drug Resistance, Fungal, Saccharomyces cerevisiae Proteins, Echinocandins, Lipopeptides, Calcineurin Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.